(Q37764962)

22 August 2017

1 reference

title

Hepatic encephalopathy as a complication of liver cirrhosis: an Asian perspective (English)

1 reference

22 August 2017

0 references

hepatic encephalopathy

1 reference

Hisataka Moriwaki

1

1 reference

22 August 2017

Makoto Shiraki

series ordinal

2

1 reference

22 August 2017

Junpei Iwasa

series ordinal

3

1 reference

22 August 2017

Yoichi Terakura

series ordinal

4

1 reference

22 August 2017

publication date

1 May 2010

1 reference

Journal of Gastroenterology and Hepatology

22 August 2017

published in

1 reference

22 August 2017

volume

25

1 reference

22 August 2017

issue

5

1 reference

22 August 2017

page(s)

858-863

1 reference

Post-feeding hyperammonaemia in patients with transjugular intrahepatic portosystemic shunt and liver cirrhosis: role of small intestinal ammonia release and route of nutrient administration.

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06242.X

Current theories on the pathogenesis of hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06242.X

Proton magnetic resonance spectroscopy of the brain in symptomatic and asymptomatic patients with liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06242.X

Evidence for gamma-aminobutyric acid as the inhibitor of gamma-aminobutyric acid binding in the plasma of humans with liver disease and hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06242.X

Prevalence of subclinical hepatic encephalopathy in cirrhotic patients in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06242.X

Somatosensory evoked potentials in subclinical portosystemic encephalopathy: a comparison with psychometric tests.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06242.X

The number connection tests A and B: interindividual variability and use for the assessment of early hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06242.X

Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06242.X

Bright basal ganglia in T1-weighted magnetic resonance images are frequent in patients with portal vein thrombosis without liver cirrhosis and not suggestive of hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06242.X

Value of the apparent diffusion coefficient for quantification of low-grade hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06242.X

Chronic hepatitis B virus infection in Asian countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06242.X

Global prevalence of putative haemochromatosis mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06242.X

ESPEN Guidelines on Enteral Nutrition: Liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06242.X

Nutritional support in hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06242.X

Normal protein diet for episodic hepatic encephalopathy: results of a randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06242.X

Lactitol vs. lactulose in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double-blind, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06242.X

Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06242.X

Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06242.X

Treatment of chronic hepatic encephalopathy with levodopa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06242.X

Branched chain amino acids in the management of chronic liver disease. Facts and fantasies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06242.X

Overview of randomized clinical trials of oral branched-chain amino acid treatment in chronic hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06242.X

Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06242.X

Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06242.X

Alternative pathway therapy for hyperammonemia in liver failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06242.X

L-ornithine and phenylacetate synergistically produce sustained reduction in ammonia and brain water in cirrhotic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06242.X

L-ornithine phenylacetate attenuates increased arterial and extracellular brain ammonia and prevents intracranial hypertension in pigs with acute liver failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06242.X

Prognostic value of energy metabolism in patients with viral liver cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06242.X

Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06242.X

Long-term oral branched chain amino acids in patients undergoing chemoembolization for hepatocellular carcinoma: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06242.X

10.1111/J.1440-1746.2010.06242.X

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference